Wass R - Search Results

1

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.

Hochmair MJ, Fabikan H, Illini O, Weinlinger C, Setinek U, Krenbek D, Prosch H, Rauter M, Schumacher M, Wöll E, Wass R, Brehm E, Absenger G, Bundalo T, Errhalt P, Urban M, Valipour A. Hochmair MJ, et al. Among authors: wass r. Pharmaceuticals (Basel). 2020 Nov 7;13(11):371. doi: 10.3390/ph13110371. Pharmaceuticals (Basel). 2020. PMID: 33171712 Free PMC article.

2

Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.

Lang D, Brauner A, Huemer F, Rinnerthaler G, Horner A, Wass R, Brehm E, Kaiser B, Greil R, Lamprecht B. Lang D, et al. Among authors: wass r. Cancers (Basel). 2021 Dec 24;14(1):93. doi: 10.3390/cancers14010093. Cancers (Basel). 2021. PMID: 35008255 Free PMC article.

3

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study.

Lang D, Haslinger W, Akbari K, Scala M, Hergan B, Asel C, Horner A, Wass R, Brehm E, Kaiser B, Lamprecht B. Lang D, et al. Among authors: wass r. Lung Cancer (Auckl). 2020 Dec 18;11:113-121. doi: 10.2147/LCTT.S286228. eCollection 2020. Lung Cancer (Auckl). 2020. PMID: 33376433 Free PMC article.

4

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.

Wass R, Hochmair M, Kaiser B, Grambozov B, Feurstein P, Weiß G, Moosbrugger R, Sedlmayer F, Lamprecht B, Studnicka M, Zehentmayr F. Wass R, et al. Cancers (Basel). 2022 Jun 30;14(13):3226. doi: 10.3390/cancers14133226. Cancers (Basel). 2022. PMID: 35804997 Free PMC article.

5

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.

Lang D, Huemer F, Rinnerthaler G, Horner A, Wass R, Brehm E, Akbari K, Granitz M, Hutarew G, Kaiser B, Greil R, Lamprecht B. Lang D, et al. Among authors: wass r. Target Oncol. 2019 Dec;14(6):707-717. doi: 10.1007/s11523-019-00679-9. Target Oncol. 2019. PMID: 31654203 Free PMC article.

6

Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.

Grambozov B, Nussdorfer E, Kaiser J, Gerum S, Fastner G, Stana M, Gaisberger C, Wass R, Studnicka M, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: wass r. Curr Oncol. 2021 May 13;28(3):1835-1846. doi: 10.3390/curroncol28030170. Curr Oncol. 2021. PMID: 34068043 Free PMC article.

7

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.

Grambozov B, Wass R, Stana M, Gerum S, Karner J, Fastner G, Studnicka M, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: wass r. Thorac Cancer. 2021 Apr;12(8):1162-1170. doi: 10.1111/1759-7714.13884. Epub 2021 Feb 14. Thorac Cancer. 2021. PMID: 33586228 Free PMC article.

8

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation.

Zehentmayr F, Sprenger M, Rettenbacher L, Wass R, Porsch P, Fastner G, Pirich C, Studnicka M, Sedlmayer F. Zehentmayr F, et al. Among authors: wass r. Thorac Cancer. 2019 Feb;10(2):321-329. doi: 10.1111/1759-7714.12966. Epub 2019 Jan 7. Thorac Cancer. 2019. PMID: 30618120 Free PMC article. Clinical Trial.

9

First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes.

Lang D, Ritzberger L, Rambousek V, Horner A, Wass R, Akbari K, Kaiser B, Kronbichler J, Lamprecht B, Gabriel M. Lang D, et al. Among authors: wass r. Cancers (Basel). 2021 Dec 3;13(23):6096. doi: 10.3390/cancers13236096. Cancers (Basel). 2021. PMID: 34885206 Free PMC article.

10

Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.

Grambozov B, Wolf F, Kaiser J, Wass R, Fastner G, Gaisberger C, Rettenbacher L, Studnicka M, Pirich C, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: wass r. Thorac Cancer. 2020 Feb;11(2):369-378. doi: 10.1111/1759-7714.13276. Epub 2019 Dec 19. Thorac Cancer. 2020. PMID: 31855325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters